William Blair & Company
PNT

William Blair & Company’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

William Blair & Company’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-250,528
Closed -$1.67M – 1862
2023
Q3 		$1.67M Sell
250,528
-15,002
-6% -$125K 0.01% 703
2023
Q2 		$2.41M Buy
+265,530
New +$2.34M 0.01% 624

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

William Blair & Company's PNT Position: Q4 2023 in Review

William Blair & Company sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 250,528 shares — an estimated $1.67M sold.

William Blair & Company first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $2.41M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • William Blair & Company reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • William Blair & Company sold 250,528 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $1.67M.
  • William Blair & Company first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • William Blair & Company's POINT Biopharma Global Inc. Common Stock position peaked at $2.41M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on William Blair & Company's 13F filing for Q4 2023, filed 12 Feb 2024.